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Abstract
Background and Purpose: The lectin-like oxidised LDL receptor-1 (OLR1) gene encodes a scavenger receptor implicated in
the pathogenesis of atherosclerosis. Although functional roles have been suggested for two variants, epidemiological
studies on OLR1 have been inconsistent. Methods - We tested the association between the non-synonymous substitution
K167N (rs11053646) and intima media thickness of the common carotid artery (CCA-IMT) in 2,141 samples from the
Progression of Lesions in the Intima of the Carotid (PLIC) study (a prospective population-based study).
Results: Significantly increased IMT was observed in male carriers of the minor C (N) allele compared to GC and GG (KN and
KK) genotype. Functional analysis on macrophages suggested a decreased association to Ox-LDL in NN carriers compared to
KN and KK carriers which is also associated with a reduced OLR1 mRNA expression. Macrophages from NN carriers present
also a specific inflammatory gene expression pattern compared to cells from KN and KK carriers.
Conclusions: These data suggest that the 167N variant of LOX-1 receptor affects the atherogenic process in the carotid
artery prior to evidence of disease through an inflammatory process.
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Introduction
Atherosclerosis is a complex disease. Endothelial dysfunction,
activation and inflammation, proteolysis, apoptosis, platelet aggrega-
tion, thrombosis and angiogenesis are the processes involved in the
phases of the disease [1]. The effects of environment on these
phenotypes are also impacted by underlying genetic predisposition
that may not impact all endo-phenotypes in the same way. The
internalization of Ox-LDL has a critical effect in both endothelial
dysfunction and inflammation [2]. This process is mediated by
several scavenger receptors [3], including the lectin-like oxidized low-
density lipoprotein receptor 1 (LOX-1) [4]. LOX-1 is mainly
expressed in macrophages, endothelial, and smooth muscle cells. Its
expression is induced by pro-inflammatory stimuli, such as shear
stress, TNFa, LPS and infections [5,6,7]. LOX-1 is encoded by the
OLR1 gene, mapped to chromosome 12p13 [8]. A Single Nucleotide
Polymorphisms (SNP) on exon 4, rs11053646 (G501C), leads to an
amino acidic substitution (lysine to asparagine at position 167,
K167N). Functional analyses suggested that a change on the positive
isopotential surface determined by this variant could lead to a
decreased binding and internalization of Ox-LDL [9].
Despite the evidence for a functional role of this polymorphism,
results from epidemiological studies are equivocal [10,11,12,13,14,15].
Of note, a gender specific association has been recently described
between the C [N] allele and prevalence of carotid plaque in females of
Dominican-Hispanic origin [16].
A direct association between circulating Ox-LDL and Intima
Media Thickness (IMT) of the Common Carotid Artery has been
demonstrated in previous studies [17,18,19]. Circulating Ox-LDL
and IMT resulted inversely related to anti-OxLDL antibodies
titulation, suggesting that immune response to Ox-LDL could
have a protective role in the early phases of the disease [17,18,19].
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Since the N allele of rs11053646 is associated to lower levels of
Ox-LDL internalization [9], we tested whether this allele is
associated to CCA-IMT in the Progression of Lesions in the
Intima of the Carotid Artery (PLIC) study (a prospective
population-based study representative of the population of
Northern Milan, Italy).
In addition, we investigated functional effects in macrophages
obtained from carriers of different genotypes to test the hypothesis
that N allele could have a reduced receptor activity. If this is true,
that should result in a less effective Ox-LDL binding and
internalization and therefore display lower levels of OLR1 RNA
expression (as it is stimulated by Ox-LDL internalization itself).
Methods
Study sample
The use of human material in this study conforms to the
principles outlined in the declaration of Helsinki. A cohort of
2,141 subjects attending the Atherosclerosis Centre in Bassini
Hospital, Department of Pharmacological Sciences (University of
Milan, Italy), was recruited for the PLIC study. This study has
been previously widely described and the samples utilized in
genetic studies [20,21,22,23,24,25,26].
Genotyping
Genomic DNA was extracted using the Flexigene DNA kit
(Qiagen, Milan, Italy) according to the manufacturer’s instruc-
tions. SNP genotyping was performed through the Taqman
Genotyping Assay (ID: C__22273024_10, Applied Biosystems,
Foster City, CA) on a BioRad machine. One mL (10–200 ng) of
DNA was analysed for genotyping.
A Genotype confirmation of,50 samples was obtained through
Sanger sequencing on an ABI3130 machine (Methods S1).
Statistical analysis
Group differences were determined by using Analysis of
Variance (ANOVA) for continuous variables and chi-square
analysis for categorical variables. Group differences with P,0.1
were considered as suggestive and P,0.05 was deemed as
statistically significant. Plots were generated using Excel and data
were analyzed using the SPSS Software (http://www.spss.it/) on a
Windows Machine.
Peripheral blood mononuclear cell (PBMC) isolation and
culture
Peripheral blood mononuclear cells (PBMCs) were obtained
from two subjects carrying the CC genotype (NN) and eight CG
and GG subjects (KN and KK). These subjects were healthy and
of comparable age, gender and blood lipid profiles. Blood samples
diluted 1:3 in phosphate-buffered saline (PBS; 15 mL, PH 7.4)
were layered onto 4 mL of Ficoll-Hypaque (Amersham, Milan,
Italy) and centrifuged at 300 g for 35 min. PBMCs were removed
from the interface and washed twice (10 min, 300 g) in PBS before
being counted.
PBMCs were re-suspended in RPMI supplemented with
antibiotics and 10% serum bovine serum albumin and plated in
6-well plates and incubated for 1 1/2 hours at 37uC. Non-
adherent cells were removed by rinses of PBS (46). For addressing
the association of Ox-LDL with macrophages, 1 week after the
isolation, monocyte–derived macrophages were incubated with or
without TNFa (10 ng/mL) for 18 h followed by Ox-LDL (6.25 or
12.5 mg/mL) for 1 h and then processed for FACS analysis.
Expression analysis
Total RNA was extracted from circulating monocytes and from
monocytes-derived macrophages cells according to manufacturer’s
Trizol protocol [27] and reverse transcription was performed as
described [20]. Three mL of cDNA was amplified by real-time
quantitative polymerase chain reaction (PCR) with 16Sybr green
universal PCR mastermix (Applied Biosystems, Foster City, CA).
The specificity of the Sybr green fluorescence was tested by
plotting fluorescence as a function of temperature to generate a
melting curve of the amplicon. The melting peaks of the amplicons
were as expected (data not shown). The primers used are reported
in (Table S1). HPTR1 was used as internal reference. Each sample
was analyzed in duplicate using the Applies Biosystems 7000
machine and each experiment was replicated twice. The PCR
amplification was related to a standard curve ranging from 10211
to 10214 mol/L.
Flow cytometry
Isolation and modification of low density
lipoproteins. LDLs (d=1.019–1.063 g/mL) were isolated from
fresh plasma of normolipidemic healthy volunteers by sequential
ultracentrifugation [28]. Protein content was determined by the
method of Lowry, using BSA as a standard [29]. Ox-LDL were
generated with CuSO4 5 mM as described [30].
Fluorescent labeling of lipoproteins. For lipid labeling,
Ox-LDL were incubated with the fluorescent dye DiO (300 mg
DiO/mg OxLDL protein) in PBS for 18 h at 4uC, passed over a
PD10 column to remove unbound DiO, then centrifuged in a
TL100 centrifuge at d = 1,063 g/mL for 2 h at 4uC. DiO-labeled
lipoproteins were passed through a PD10 column and protein
content was determined by the method of Lowry [29].
Cell-association studies. Cells were incubated at 37uC for
1 h with the indicated concentrations of Ox-LDL labeled with
DiO. Cells were then washed three times with cold PBS, detached
by scraping, fixed in 1% paraformaldehyde and immediately
subjected to fluorescence flow cytometry using a FACScan (Becton
Dickinson). For each sample 10,000 events were analyzed; data
were processed using the CellQuest program (Becton Dickinson)
[31].
Results
The relative frequencies of the three OLR1 genotypes are shown
in Table 1. No deviation from Hardy Weinberg equilibrium was
observed.
The presence of the N allele was not associated with any of the
cardiometabolic variables analysed (Table 2) and the increase in
IMT observed was not statistically significant (0.6460.12 mm,
0.6660.11 mm and 0.6960.07 for KK, KN and NN respectively,
p = n.s). As a recent paper showed a gender related effect of the N
Table 1. Observed and expected frequencies of OLR1 K167N
polymorphism in the PLIC population and comparison with
those reported in dbSNP (http://www.ncbi.nlm.nih.gov/
projects/SNP/snp_ref.cgi?rs = 11053646).
KK KN NN p-value
Observed frequency 1988 (87%) 283 (12%) 5 (0.02%) 0.12
Expected frequency 1992.4 (88%) 274.1 (12%) 9.4 (0.04%)
dbSNP frequency CEU 75% 25% 0%
doi:10.1371/journal.pone.0031086.t001
OLR1 and Intima Media Thickness
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allele [16], data were next analysed according to gender. The
trend observed for systolic and diastolic blood pressures in the
general population, was lost when stratifying by gender. However,
in males, KK subjects showed a lower IMT compared to carriers
of the N allele (NN and KN) [(0.6660.13) mm and (0.6960.13)
mm respectively, p,0.05, Table 3]. No other phenotype was
associated with this variant. Of note, no major phenotypes were
observed in women. Furthermore, a second functional variation
on OLR1, rs3736235 [32], was genotyped and no significant
difference in cardiometabolic variables or IMT between carriers of
the different genotypes was observed.
To next investigate how the presence of the LOX-1 NN genotype
could be associated with an increased IMT, we performed a series
on in vitro analysis in monocytes and macrophages from carriers of
the KK, the KN and the NN genotype.
Under basal conditions, as expected, OLR1 expression was very
low in PBMCs. The same was true for Nf-kB (nuclear factor kappa-
light-chain-enhancer of activated B cells), ERK1/2 (extracellular
related kinase 1/2), IL-6 (Interleukin-6), CD40 (cluster of
designation 40), CD40 ligand, and MMP9. The mRNA expression
of all tested genes in PBMCs from KK, KN and NN subjects was
similar (Figure 1, Table S2). Next, to investigate LOX-1 NN,
LOX-1 KN and LOX-1 KK effects in the proper atherosclerotic-
prone setting, monocyte were differentiated into macrophages and
gene expression analysis was performed. Nf-kB mRNA expression
was significantly increased in NN compared to KN and KK
macrophages (Figure 2 and Table S3). The same trend was
observed for ERK1/2, although this difference did not reach a
statistical significance (Figure 2 and Table S3). On the contrary,
OLR1 RNA expression was significantly lower in NN and KN
macrophages (Figure 2 and Table S3) compared to KK
macrophages.
Finally we tested whether different LOX-1 genotypes might
affect the association to Ox-LDL. Ox-LDL associate to NN
macrophages to a lower extent compared to KN and KK
macrophages (Fig. 3, Table S3). This result is agreement with
previous findings in an African green monkey cell line (COS-1) (9).
This was true when cells were incubated in the presence of Ox-
LDL with or without LOX-1 induction obtained following
incubation with TNFa (Figure 3, Table S4).
To summarize results, we identified the LOX-1 167N (C) allele
as associated to higher level to IMT in males prior to any evidence
of disease, we confirmed in vivo that NN macrophages internalize
Ox-LDL to a lower extent and found evidences suggestive for an
immune reaction to circulating Ox-LDL in early phases of the
disease.
Discussion
The main finding of this paper is that males from the general
population with the C (N) allele of the ORL1 gene have an
increased IMT. Since no other phenotype resulted associated to
this variant, this suggests it to be an independent association. To
date, inconclusive results on the epidemiology of OLR1 gene
polymorphisms were obtained. Both a protective role for MI and
CAD severity [10,12,14] and a risk role for MI and hypertension
[11,15] for the C (N) allele were proposed. Also, the replication of
these results was rarely tested and never obtained [14], leading to
the conclusion that these were spurious associations. Furthermore,
a recent meta-analysis considered all studies that have been
published on the relationship between OLR1 polymorphisms and
MI, finding partially contrasting results and an overall effect that is
non-significant when considering the K167N variation [33].
Recently, a study reported the association between the C (N)
allele and carotid plaque prevalence in 167 women from a
Dominican-Hispanic population [16]. We extend these findings,
showing an allele’s association in 926 males from the PLIC
population and analysing the molecular players and pathological
responses associated with leucocytes and macrophages from NN,
KN and KK subjects.
Previous data on COS-1 cells over expressing either GG (KK)
or CC (NN) LOX-1 showed that KK COS-1 cells bind and
internalize less ox-LDL than CC (NN) [7]. Here for the first time
to our knowledge, we addressed this question in macrophages
derived from peripheral mononuclear cells from KK and NN
subjects, after stimulation with Ox-LDL and TNFa. We would
expect that C (N) allele of the ORL1 gene to be a protective factor,
especially in the late phases of the disease. However, past studies
demonstrated that circulating Ox-LDL trigger immune response
and are associated to an increased IMT [17,18,19]. This suggests
that, in non-pathological conditions, a decrease of macrophage-
Ox-LDL association, and hence an increase of circulating Ox-
LDL, may set the stage to trigger an immune response.
We report evidence that macrophages carrying the functional
GG (KK) receptor display higher levels of OLR1’s RNA, but lower
RNA expression levels of an inflammatory marker such as Nf-kB,
suggesting again that, in non-pathological conditions, a less-
functional CC (NN) receptor, could be associated to an increased
inflammation.
Regarding the difference between genders of our study and that
of Wang and co-workers, there are several aspects that have to be
taken into account: First, we studied a completely different
Table 2. K167N polymorphism in the PLIC population.
K167N (rs11053646)
KK KN+NN p-value
Age (years) 54.33+/20.260 54.43+/20.680 ns
Systolic blood
pressure (mmHg)
133.33+/20.420 131.23+/21.050 0.070
Diastolic blood
pressure (mmHg)
82.98+/20.220 81.85+/20.600 0.095
Total cholesterol
(mmol L)1)
221.77+/20.890 220.07+/22.400 ns
HDL cholesterol
(mmol L)1)
56.13+/20.340 54.07+/20.810 ns
LDL cholesterol
(mmol L)1)
144.205+/20.820 144.717+/22.180 ns
Triglycerides (mmol L)1) 108.11+/21.420 105.58+/23.280 ns
IMTm (mm) 0.645+/20.003 0.658+/20.007 0.080
doi:10.1371/journal.pone.0031086.t002
Table 3. Statistical observations on the association between
OLR1 polymorphisms in males.
K167N (rs11053646)
KK KN+NN p-value
Systolic blood pressure (mmHg) 135.830+/20.630 133.39+/21.47 ns
Diastolic blood pressure (mmHg) 84.42+/20.34 83.17+/20.91 ns
IMTm (mm) 0.663+/20.004 0.694+/20.011 0.050*
doi:10.1371/journal.pone.0031086.t003
OLR1 and Intima Media Thickness
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population. It is known, in fact, that Hispanics have different
susceptibility to cardiovascular disease, only partially explainable
by environmental factors [34]. Furthermore OLR1 variants display
highly different frequencies in different populations (p,0.0001
comparing European ancestry HapMap populations and African
HapMap populations, and p= 0.04 comparing European ancestry
populations and Mexicans in HapMap populations. Details about
analyses on HapMap samples are available upon request) Second,
gene-regulation for many quantitative traits differs significantly
between males and females. In particular, evidences suggested a
differential genotype by sex interaction on variation on Paraox-
onase-1 (PON1, a calcium dependent esterase known to have
antioxidant properties) activity in Mexican American populations
[35]. We tested for interaction between available functional
variants on both OLR1 and PON1 from the HapMap dataset and
found suggestive evidences for differences in gene-by-gender
Figure 1. Gene expression levels from Peripheral Mononuclear Cells (PBMCs) of KK, KN and NN carriers. Expression levels are measured
by the log (DDCt) obtained comparing each gene’s expression with that of the housekeeping gene, HPRT1. (Nf-kB: nuclear factor kappa-light-chain-
enhancer of activated B cells, ERK1/2: extracellular related kinase 1/2, IL-6: Interleukin-6, CD40: cluster of designation 40, CX3CR1: CX3 chemokine
receptor 1, TLR-4: Toll-like receptor 4, MMP: metalloproteinase).
doi:10.1371/journal.pone.0031086.g001
Figure 2. OLR1 expression in KK, KN and NN in differentiated macrophages. (Nf-kB: nuclear factor kappa-light-chain-enhancer of activated B
cells, ERK1/2: extracellular related kinase 1) (* p,0.05 vs KK).
doi:10.1371/journal.pone.0031086.g002
OLR1 and Intima Media Thickness
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interactions in populations with different ancestry (details about
analyses on HapMap samples are available upon request). Third,
Wang and co-workers focused their analysis on the presence of
plaque, (advanced atherosclerosis) while we focused on IMT
(atherogenesis) thus suggesting a dual role for OLR1 in different
phases of the atherogenic process.
Although we have to recognize some limits of our study,
including the low number of NN individuals, this is the first study
which was able to directly carry on functional tests on human NN
PBMCs and macrophages and represents, to date, the second
largest study which investigated the role of LOX-1 functional
polymorphism in the onset of cardiovascular disorders. Therefore,
these findings support the relevance of OLR1 in vascular disorders
at epidemiological and functional level.
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